Frontlight ResearchEarly access
TerminatedNo phase
Low Intensity Focused Ultrasound for Binge Eating Disorder
Key facts
- Who runs it
- Ali Rezai
- Where
- Morgantown, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 4 people enrolled
- Started
- 31 Oct 2024
- Ended
- 30 Sept 2026
- Type of study
- Interventional
- Treatments tested
- LIFU Neuromodulation
- Record updated
- 17 November 2026
- Why it stopped
- poor accrual,
Who can take part
- Age
- 22 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Males and non-pregnant females, 22 - 65 years of age
- Participant meets DSM-5 criteria for moderate to extreme BED
- Weight ≤450lb to accommodate in MRI
- Shoulder width of ≤65 inches to accommodate in MRI
- The neuromodulation targets are visible on MRI for target selection
- Participant is able and willing to give informed consent
Who cannot take part
- Evidence of substance (alcohol or other drug) use disorder during the previous 12 months (assessed via SCID-5)
- Use of any medications that, in the opinion of the Investigator, may put the participant at higher risk for AEs, or impair the participant's ability to perform complete study procedures
- Participant is considered to be a poor surgical or study candidate, which may include, but is not limited to the following: any medical, social, or psychological problem that could complicate the required procedures and evaluations of the study in the judgment of the investigator
- Unable to undergo MR-imaging because of implanted pacemakers, medication pumps, aneurysm clips, metallic prostheses (including metal pins and rods, heart valves or cochlear implants), shrapnel fragments, permanent make-up or small metal fragments in the eye that welders and other metal workers may have, or if candidates are uncomfortable in small spaces (have claustrophobia)
- Participants with more than 30% of the skull area traversed by the sonication pathway are covered by scars, scalp disorders (e.g., eczema), atrophy of the scalp, or implanted objects in the skull or the brain
- Participants with known untreated or unstable cardiac status or hypertension
- Past or present diagnosis of schizophrenia, psychotic disorder or bipolar disorder (assessed via SCID-5)
- Participant who is currently participating in another clinical investigation with an active treatment arm
- Participant is pregnant/lactating or planning to be pregnant
Where in United States
- West Virginia University Rockefeller Neuroscience InstituteMorgantown, United States
About the trial
What the trial wants to find out
This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)
The group in the trial
- LIFU NeuromodulationTreatment being tested
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Binge Eating Disorder (BED)
- Record updated
- 17 November 2026